OK Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 16, 2021 at 07:34 pm EDT
Share
OK Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 300.510 million compared to TWD 319.298 million a year ago. Operating loss was TWD 5.357 million compared to operating Income of TWD 13.936 million a year ago. Net loss was TWD 166,000 compared to net income of TWD 21.003 million a year ago. Basic eps was TWD 0 compared to TWD 0.27 a year ago. Diluted eps was TWD 0 compared to TWD 0.25 a year ago. For the half year, sales was TWD 596.455 million compared to TWD 690.088 million a year ago. Operating income was TWD 12.723 million compared to TWD 59.701 million a year ago. Net income was TWD 29.597 million compared to TWD 67.677 million a year ago. Basic earnings per share was TWD 0.31 compared to TWD 0.88 a year ago. Diluted earnings per share was TWD 0.27 compared to TWD 0.82 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
